𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparative effects of fosinopril and nifedipine on regression of left ventricular hypertrophy in hypertensive patients: A double-blind study

✍ Scribed by H. G. Kirpizidis; G. S. Papazachariou

Publisher
Springer US
Year
1995
Tongue
English
Weight
336 KB
Volume
9
Category
Article
ISSN
0920-3206

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effects of adalat (nifedipine) on left v
Effects of adalat (nifedipine) on left ventricular hemodynamics in angina pectoris: Comparative study with propranolol
✍ Kurita, Akira ;Ogawa, Takeshi ;Kanazawa, Masakuni ;Hamamato, Hiromu ;Mabuchi, Ge πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 408 KB

## Abstract The hemodynamic effects of nifedipine and propranolol administered intravenously were studied in 17 patients with angina pectoris. Nine patients received nifedipine and eight received propranolol. The hemodynamic parameters were compared at rest and during supine bicycle exercise at wor

The effects of ACE inhibitor therapy on
The effects of ACE inhibitor therapy on left ventricular myocardial mass and diastolic filling in previously untreated hypertensive patients: A Cine MRI study
✍ U. Hoffmann; S. Globits; T. Stefenelli; C. Loewe; K. Kostner; H. Frank πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 210 KB

## Abstract Cardiac remodeling in case of hypertension induces hypertrophy of myocytes and elevated collagen content and, subsequently, impaired diastolic filling of the left ventricle. The purpose of this prospective study was to evaluate changes of left ventricular (LV) myocardial mass, as well a

A double-blind comparison of the effects
A double-blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia
✍ U. Hauf-Zachariou; L. Widmann; B. ZΓΌlsdorf; M. Hennig; P. D. Lang πŸ“‚ Article πŸ“… 1993 πŸ› Springer 🌐 English βš– 576 KB

We have studied 250 patients with mild to moderate essential hypertension (diastolic blood pressure 95-114 mmHg) and dyslipidaemia (high-density lipoprotein cholesterol (HDL-C) below 1.03 mmol.l-1, total cholesterol 5.17-9.05 mmol.l-1, and triglycerides 2.26-5.64 mmol.l-1) in a controlled double-bli